Factors associated with seropositive antibodies to Brucella melitensis in the Nakhon Nayok, Thailand

Journal of the Medical Association of Thailand

Volumn 95, Issue SUPPL.12, 2012, Pages

  Ekpanyaskul, Chatchai ^a   Santiwattanakul, Somchai ^a   Tantisiriwat, Worapot ^a   Buppanharun, Wanchai ^a  

^a SRINAKHARINWIROT UNIVERSITY   (Thailand)

Author keywords

Brucella melitensis; Seroprevalence; Zoonosis

Indexed keywords

ADULT; AGGLUTINATION TEST; ARTICLE; BRUCELLA MELITENSIS; BRUCELLOSIS; COMMUNITY PROGRAM; CROSS-SECTIONAL STUDY; DISEASE SURVEILLANCE; FEMALE; HEALTH EDUCATION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; RISK FACTOR; SERODIAGNOSIS; SEROPREVALENCE; THAILAND;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIBODIES, BACTERIAL; BRUCELLOSIS; CATTLE; CATTLE DISEASES; CROSS-SECTIONAL STUDIES; DISEASE OUTBREAKS; FEMALE; GOAT DISEASES; GOATS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEROLOGIC TESTS; THAILAND;

EID: 84876894982     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Bruce D. Note on the discovery of a microorganism in Malta fever. Practioner 1887; 39: 161-70.
2. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis 2006; 6: 91-9.
3. Manosuthi W, Thummakul T, Vibhagool A, Vorachit M, Malathum K. Case report: Brucellosis: a re-emerging disease in Thailand. Southeast Asian J Trop Med Public Health 2004; 35: 109-12.
4. Paitoonpong L, Ekgatat M, Nunthapisud P, Tantawichien T, Suankratay C. Brucellosis: the first case of King Chulalongkorn Memorial Hospital and review of the literature. J Med Assoc Thai 2006; 89: 1313-7.
5. Buppanharun W, Santiwatanakul S, Chansiri K, Varavithya V, Wongamorntham S, Tantisiriwat W. Epidemiology of brucellosis at HRH Princess Sirindhorn Medical Center, Srinakharinwirot University. Proceedings of 10th Western Pacific Congress on Chemotherapy and Infectious Diseases.; 2006 December 3-6; Fukuoka. Fukuoka: The Japanese Society of Chemotherapy, 2006.
6. Cobel MJ. Brucellosis in humans and animals. Geneva: World Health Organization; 2006.
7. Chan YH. Biostatistics 202: logistic regression analysis. Singapore Med J 2004; 45: 149-53.
8. Moreno E, Cloeckaert A, Moriyon I. Brucella evolution and taxonomy. Vet Microbiol 2002; 90: 209-27.
9. Sharma R, Chisnall C, Cooke RP. Evaluation of in-house and commercial immunoassays for the sero-diagnosis of brucellosis in a non-endemic low prevalence population. J Infect 2008; 56: 108-13.
10. Reid AJ. Brucellosis-a persistent occupational hazard in Ireland. Int J Occup Environ Health 2005; 11: 302-4.
11. Kozukeev TB, Ajeilat S, Maes E, Favorov M. Risk factors for brucellosis-Leylek and Kadamjay districts, Batken Oblast, Kyrgyzstan, January-November, 2003. MMWR Morb Mortal Wkly Rep 2006; 55 (Suppl 1): 31-4.
12. Abo-Shehada MN, Odeh JS, Abu-Essud M, Abuharfeil N. Seroprevalence of brucellosis among high risk people in northern Jordan. Int J Epidemiol 1996; 25: 450-4.
13. Mishal J, Ben Israel N, Levin Y, Sherf S, Jafari J, Embon E, et al. Brucellosis outbreak: analysis of risk factors and serologic screening. Int J Mol Med 1999; 4: 655-8.
14. Almuneef MA, Memish ZA, Balkhy HH, Alotaibi B, Algoda S, Abbas M, et al. Importance of screening household members of acute brucellosis cases in endemic areas. Epidemiol Infect 2004; 132: 533-40.